Af­ter rais­ing $140M, SPAC will take biotech pub­lic with a frac­tion of planned funds

2 days ago
Financing

Kite's head of re­search leaves for Flag­ship start­up Sonata

3 days ago
People
Startups

Con­tra­cep­tive mak­er Evofem lets com­mer­cial chief go, cuts CEO pay 40% to save cash

3 days ago
People

Karuna to raise $400M in mar­ket a day af­ter pos­i­tive read­out of schiz­o­phre­nia drug

3 days ago
Financing

So­bi's PhI­II gout win sets up a po­ten­tial ri­val­ry with fu­ture Am­gen as­set

3 days ago
R&D

Ab­b­Vie cel­e­brates decade of phar­ma work in newest cor­po­rate cam­paign

3 days ago
Pharma
Marketing

Most dos­es of No­vo Nordisk's Ozem­pic are re­moved from FDA drug short­age list af­ter sup­ply is­sues

3 days ago
Pharma
Manufacturing

FDA in­di­cates will­ing­ness to ap­prove Bio­gen ALS drug de­spite failed PhI­II study

3 days ago
R&D
FDA+

Sy­neos Health inks deal with Mi­crosoft to use AI tech­nol­o­gy

3 days ago
Deals
AI

'No find­ing of re­search mis­con­duc­t': MIT ends 3.5-year re­view of biotech founder, pro­fes­sor Sasisekha­ran

3 days ago
People

No­var­tis and Bio­gen pull out of neu­ro drug part­ner­ships with Sang­amo

4 days ago
Deals
Cell/Gene Tx

Karuna’s schiz­o­phre­nia drug clears an­oth­er PhI­II as biotech seeks 2024 launch

4 days ago
R&D

Seagen goes to Pfiz­er for $43B; Sanofi buys di­a­betes part­ner Proven­tion; Cri­sis avert­ed in SVB demise; and more

6 days ago
Weekly

Ve­rastem's new cam­paign aims to make dis­tinc­tions in rare type of ovar­i­an can­cer

6 days ago
Pharma
Marketing

Pfiz­er's Bourla and Mod­er­na's Ban­cel saw com­pen­sa­tion bumps in 2022

6 days ago
People
Pharma

BeiGene de­cides not to li­cense DKK1 drug, but keeps PD-1 com­bo tri­al in gas­tric can­cer

6 days ago
Deals

Mod­er­na's 'sur­prise' IP court or­der could set up a big set­tle­ment for Roivant, Ar­bu­tus — an­a­lysts

Last week
Law

Ul­tragenyx adds new CMO with in­ter­nal pro­mo­tion; Au­to­lus CFO to leave for Mor­phoSys — but not quite yet

Last week
Peer Review

Am­gen cites in­fla­tion, pres­sure on drug prices in 450-per­son lay­off

Last week
People
Pharma

Mer­ck­'s Keytru­da plus TIG­IT com­bo proves less ef­fec­tive than chemo in open-la­bel lung can­cer study

Last week
R&D
Pharma

Vi­iV's newest cam­paign aims to nor­mal­ize sex and health dis­cus­sions to help HIV pre­ven­tion among Black women

Last week
Pharma
Marketing

No­vo Nordisk sus­pend­ed from lead­ing UK trade group over obe­si­ty mar­ket­ing 'breach'

Last week
Pharma
Marketing

Seagen qui­et­ly doles out cell ther­a­py patent rights, but scope re­mains un­clear

Last week
Deals
Cell/Gene Tx

'Very re­al' head­winds: With lean­er staff, can­cer vac­cine mak­er search­es for help

Last week
Financing
R&D
First page Previous page 12345 Next page Last page